BPG is committed to discovery and dissemination of knowledge
Featured Articles
3/22/2023 11:42:05 AM | Browse: 551 | Download: 1505
Publication Name World Journal of Hepatology
Manuscript ID 80297
Country United States
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Cohort Study
Article Title Adherence to guideline-directed hepatocellular carcinoma screening: A single-center US experience
Manuscript Source Unsolicited Manuscript
All Author List William W King, Raymond Richhart, Tyler Culpepper, Maneola Mota, Debdeep Banerjee, Media Ismael, Joydeep Chakraborty, Michael Ladna, Walid Khan, Nicole Ruiz, Jake Wilson, Ellery Altshuler, Virginia Clark and Roniel Cabrera
Funding Agency and Grant Number
Corresponding Author William W King, MD, Doctor, Doctor, Department of Medicine, University of Florida, 1600 SW Archer Rd Room 4102, Gainesville, Florida 32610, United States. william.king@medicine.ufl.edu
Key Words Hepatocellular carcinoma; Cirrhosis; Health maintenance; Quality improvement; Screening; Hepatology
Core Tip This study reinforces existing knowledge that screening rates for Hepatocellular carcinoma are woefully inadequate, even in a subspecialty hepatology clinic. Unlike previous studies, ours identifies specific failure points, showing that screening failures are driven more by systemic issues than by physician or patient error.
Publish Date 2023-03-22 11:20
Citation King WW, Richhart R, Culpepper T, Mota M, Banerjee D, Ismael M, Chakraborty J, Ladna M, Khan W, Ruiz N, Wilson J, Altshuler E, Clark V, Cabrera R. Adherence to guideline-directed hepatocellular carcinoma screening: A single-center US experience. World J Hepatol 2023; 15(3): 410-418
URL https://www.wjgnet.com/1948-5182/full/v15/i3/410.htm
DOI https://dx.doi.org/10.4254/wjh.v15.i3.410
Full Article (PDF) WJH-15-410-with-cover.pdf
Full Article (Word) WJH-15-410.docx